Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This intervention consists of a mixture of essences and essential oils delivered via a nasal stick for olfactory stimulation. It is being evaluated by the Etablissement Public de Santé Barthélemy Durand as a non-pharmacological strategy to reduce the consumption of 'as needed' (PRN) benzodiazepine receptor agonists (BZRAs) and Z-drugs in stabilized psychiatric outpatients. The therapy leverages the calming and sedative properties of specific volatile organic compounds found in essential oils to manage anxiety and sleep disturbances. By providing a sensory alternative to pharmacological sedation, the intervention aims to help patients manage acute symptoms without increasing their medication burden.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on essences + essential oils.